Abiopharma

🔍 Ortega Luisa (Executive)

Company: COCA COLA CO (KO)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Sold 19,772 shares of Common Stock, $.25 Par Value at $86.6721 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 26,209.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,628 shares of Common Stock, $.25 Par Value at $48.075 per share (Direct)
  Date: 2026-08-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 33,837.00 | transaction_form_type: 4
• Acquired 10,684 shares of Common Stock, $.25 Par Value at $59.485 per share (Direct)
  Date: 2026-08-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 44,521.00 | transaction_form_type: 4
• Acquired 21,848 shares of Common Stock, $.25 Par Value at $50.4383 per share (Direct)
  Date: 2026-08-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 66,369.00 | transaction_form_type: 4
• Sold 35,983 shares of Common Stock, $.25 Par Value at $86.5468 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 30,386.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 7,628 shares of Employee Stock Option (Right to Buy) at $48.075 per share (Derivative)
  Date: 2026-08-06 | Code: M | Expires: 2029-04-24 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
• Sold 10,684 shares of Employee Stock Option (Right to Buy) at $59.485 per share (Derivative)
  Date: 2026-08-06 | Code: M | Expires: 2030-02-20 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4
• Sold 21,848 shares of Employee Stock Option (Right to Buy) at $50.4383 per share (Derivative)
  Date: 2026-08-06 | Code: M | Expires: 2031-02-18 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5

Footnotes:

• F1: The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $86.66 to $86.695. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
• F2: The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $86.525 to $86.64. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
• F3: Options (with tax withholding right) granted on April 24, 2019 under The Coca-Cola Company 2014 Equity Plan. One-fourth of grant became execisable on each of the first, second, third and fourth anniversaries of the grant date.
• F4: Options (with tax withholding right) granted on February 20, 2020 under The Coca-Cola Company 2014 Equity Plan. One-fourth of grant became exercisable on each of the first, second, third and fourth anniversaries of the grant date.
• F5: Options (with tax withholding right) granted on February 18, 2021 under The Coca-Cola Company 2014 Equity Plan. One-fourth of grant became exercisable on each of the first, second, third and fourth anniversaries of the grant date.